Earnings Summary

ResMed Inc.’s revenue fell -99.89% since last year same period to $0.95Mn in the Q3 2022. On a quarterly growth basis, ResMed Inc. has generated -99.9% fall in its revenue since last 3-months.

ResMed Inc.’s net profit fell -99.9% since last year same period to $0.21Mn in the Q3 2022. On a quarterly growth basis, ResMed Inc. has generated -99.89% fall in its net profits since last 3-months.

ResMed Inc.’s net profit margin fell -1.66% since last year same period to 22.15% in the Q3 2022. On a quarterly growth basis, ResMed Inc. has generated 3.87% jump in its net profit margins since last 3-months.

ResMed Inc.’s price-to-earnings ratio after this Q3 2022 earnings stands at 43.52.

ResMed Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.59 - a 4.61% jump from last quarter’s estimates.

ResMed Inc.’s earning per share (EPS) estimates for the current year stand at 1.59.

ResMed Inc.’s earning per share (EPS) jumped 0% since last year same period to 1.51 in the Q3 2022. This indicates that the ResMed Inc. has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. ResMed Inc.’s return on assets (ROA) stands at 0.13.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. ResMed Inc.’s return on equity (ROE) stands at 24.35.

ResMed Inc. declared 0.44 dividend per share during the earnings announcement for Q3 2022.